Sartorius Stedim Biotech S.A. (LON:0RG8)

Sartorius Stedim Biotech Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,685	15,185	19,155	24,732	37,348	24,050
Market Cap Growth	-17.29%	-20.72%	-22.55%	-33.78%	55.29%	108.47%
Enterprise Value	16,685	17,158	22,373	25,691	37,777	24,225
Last Close Price	150.92	154.43	206.48	270.79	408.40	258.27
PE Ratio	63.75	104.87	71.14	31.83	107.31	79.91
PS Ratio	5.71	6.61	7.95	7.98	15.40	14.05
PB Ratio	4.13	4.56	8.26	11.09	25.66	18.37
P/TBV Ratio	-	-	-	46.41	163.54	112.24
P/FCF Ratio	44.92	38.63	80.91	153.46	117.67	104.17
P/OCF Ratio	23.03	22.53	29.57	45.54	63.35	64.39
EV/Sales Ratio	6.51	7.46	9.29	8.29	15.58	14.16
EV/EBITDA Ratio	24.62	32.97	39.20	24.20	43.61	46.83
EV/EBIT Ratio	37.86	52.40	54.93	27.47	48.88	53.74
EV/FCF Ratio	51.04	43.65	94.51	159.41	119.02	104.93
Debt / Equity Ratio	0.63	0.71	1.38	0.45	0.36	0.40
Debt / EBITDA Ratio	3.25	4.38	5.39	0.93	0.60	1.00
Debt / FCF Ratio	6.84	6.04	13.50	6.25	1.66	2.28
Asset Turnover	0.37	0.35	0.43	0.78	0.85	0.81
Inventory Turnover	2.18	2.01	1.62	1.85	2.13	2.27
Quick Ratio	0.42	1.05	0.49	0.53	0.59	0.59
Current Ratio	1.05	1.85	1.51	1.61	1.40	1.54
Return on Equity (ROE)	6.62%	5.33%	12.05%	41.43%	25.94%	25.56%
Return on Assets (ROA)	4.06%	3.10%	4.59%	14.62%	16.90%	13.38%
Return on Invested Capital (ROIC)	6.42%	5.19%	7.49%	29.10%	28.75%	22.62%
Return on Capital Employed (ROCE)	7.80%	5.40%	6.90%	26.20%	31.60%	22.00%
Earnings Yield	1.57%	0.95%	1.41%	3.14%	0.93%	1.25%
FCF Yield	2.23%	2.59%	1.24%	0.65%	0.85%	0.96%
Dividend Yield	0.32%	0.37%	0.29%	0.47%	0.26%	0.24%
Payout Ratio	25.43%	38.32%	42.77%	13.25%	15.13%	9.33%
Buyback Yield / Dilution	-2.03%	-5.01%	0.00%	0.01%	0.00%	-0.00%
Total Shareholder Return	-1.70%	-4.64%	0.29%	0.49%	0.26%	0.23%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.